Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TENOFOVIR for Hepatitis d: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where TENOFOVIR was used for Hepatitis d.

Most Reported Side Effects for TENOFOVIR

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 509 12.5% 95 41
Virologic failure 409 10.1% 10 10
Drug resistance 317 7.8% 9 26
Exposure during pregnancy 292 7.2% 10 21
Death 225 5.5% 224 17
Immune reconstitution inflammatory syndrome 177 4.4% 33 75
Maternal exposure during pregnancy 173 4.3% 17 28
Treatment failure 163 4.0% 2 7
Drug interaction 141 3.5% 13 48
Premature baby 126 3.1% 22 6
Drug ineffective 125 3.1% 46 23
Acute kidney injury 122 3.0% 33 68
Premature delivery 110 2.7% 0 8
Treatment noncompliance 105 2.6% 4 21
Renal impairment 90 2.2% 6 23

Other Indications for TENOFOVIR

Hiv infection (2,192) Product used for unknown indication (466) Antiretroviral therapy (243) Hepatitis b (200) Chronic hepatitis b (187) Prophylaxis against hiv infection (155) Acquired immunodeficiency syndrome (37) Prophylaxis (31) Antiviral prophylaxis (28) Hiv infection who clinical stage iii (25)

Other Drugs Used for Hepatitis d

BULEVIRTIDE (42) PEGINTERFERON ALFA-2A (37) TENOFOVIR DISOPROXIL (24) TENOFOVIR ALAFENAMIDE (11) ENTECAVIR (5) LAMIVUDINE (5) PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B (5)

Related Pages

TENOFOVIR Full Profile All Hepatitis d Drugs TENOFOVIR Demographics TENOFOVIR Timeline